Genetically Engineered Mouse Models in Cancer Research

被引:124
|
作者
Walrath, Jessica C. [1 ]
Hawes, Jessica J. [1 ]
Van Dyke, Terry [1 ]
Reilly, Karlyne M. [1 ]
机构
[1] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA
来源
关键词
RETROVIRAL INSERTIONAL MUTAGENESIS; MULTIPLE ENDOCRINE NEOPLASIA; REGULATED RNA INTERFERENCE; EMBRYONIC STEM-CELLS; TRANSGENIC MICE; COLLABORATIVE CROSS; LUNG-CANCER; CHROMOSOMAL TRANSLOCATION; TELOMERE DYSFUNCTION; ANGIOGENIC SWITCH;
D O I
10.1016/S0065-230X(10)06004-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mouse models of human cancer have played a vital role in understanding tumorigenesis and answering experimental questions that other systems cannot address. Advances continue to be made that allow better understanding of the mechanisms of tumor development, and therefore the identification of better therapeutic and diagnostic strategies. We review major advances that have been made in modeling cancer in the mouse and specific areas of research that have been explored with mouse models. For example, although there are differences between mice and humans, new models are able to more accurately model sporadic human cancers by specifically controlling timing and location of mutations, even within single cells. As hypotheses are developed in human and cell culture systems, engineered mice provide the most tractable and accurate test of their validity in vivo. For example, largely through the use of these models, the microenvironment has been established to play a critical role in tumorigenesis, since tumor development and the interaction with surrounding stroma can be studied as both evolve. These mouse models have specifically fueled our understanding of cancer initiation, immune system roles, tumor angiogenesis, invasion, and metastasis, and the relevance of molecular diversity observed among human cancers. Currently, these models are being designed to facilitate in vivo imaging to track both primary and metastatic tumor development from much earlier stages than previously possible. Finally, the approaches developed in this field to achieve basic understanding are emerging as effective tools to guide much needed development of treatment strategies, diagnostic strategies, and patient stratification strategies in clinical research.
引用
收藏
页码:113 / 164
页数:52
相关论文
共 50 条
  • [41] The Untapped Potential of Genetically Engineered Mouse Models in Chemoprevention Research: Opportunities and Challenges
    Abate-Shen, Cory
    Brown, Powel H.
    Colburn, Nancy H.
    Gerner, Eugene W.
    Green, Jeffery E.
    Lipkin, Martin
    Nelson, William G.
    Threadgill, David
    CANCER PREVENTION RESEARCH, 2008, 1 (03) : 161 - 166
  • [42] Chemoprevention of melanoma: Genetically engineered mouse models
    Merlino, G
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1357S - 1357S
  • [43] Genetically engineered mouse models of neurodegenerative diseases
    Wong, PC
    Cai, HB
    Borchelt, DR
    Price, DL
    NATURE NEUROSCIENCE, 2002, 5 (07) : 633 - 639
  • [44] Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research
    Zhou, Ting
    Kinney, Marsha C.
    Scott, Linda M.
    Zinkel, Sandra S.
    Rebel, Vivienne I.
    BLOOD, 2015, 126 (09) : 1057 - 1068
  • [45] Studying lung cancer progression: insights from genetically engineered mouse models of cancer
    Neidler, Sarah
    Murphy, Daniel J.
    LUNG CANCER MANAGEMENT, 2015, 4 (04) : 155 - 157
  • [46] RAPID VALIDATION OF CANCER GENES AND DRUG TARGETS IN GENETICALLY ENGINEERED MOUSE MODELS OF CANCER
    Huijbers, I. J.
    Bin Ali, R.
    Pritchard, C.
    Cozijnsen, M.
    Proost, N.
    Song, J. Y.
    Krimpenfort, P.
    Michalak, E.
    Jonkers, J.
    Berns, A.
    ANNALS OF ONCOLOGY, 2013, 24 : 16 - 16
  • [47] Microbial considerations in genetically engineered mouse research
    Franklin, CL
    ILAR JOURNAL, 2006, 47 (02) : 141 - 155
  • [48] Illuminating p53 function in cancer with genetically engineered mouse models
    Garcia, Patty B.
    Attardi, Laura D.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 27 : 74 - 85
  • [49] Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
    Clark, Carolyn E.
    Beatty, Gregory L.
    Vonderheide, Robert H.
    CANCER LETTERS, 2009, 279 (01) : 1 - 7
  • [50] Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations
    Ijichi, Hideaki
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (05): : 195 - 202